Fig. 4.6. A: Restraint for vascular
access—foot and ankle. Tape is
applied in order 1 through 3, as shown.
B: Foot and ankle restraint for vascular
weights of common restraint materials in use when
weighing infants for monitoring daily growth.
and regulatory agency requirement. Regulatory agencies
such as the Joint Commission, the U.S. Food and Drug
Administration (FDA), and the Centers for Medicare and
Medicaid Services (CMS) publish standards of medical
care regarding the safe use and legal requirements for
restraint implementation and maintenance (1,4,5).
7. Ensure that the infant is in a proper and functional
position that promotes flexion and midline positioning
of upper and lower extremities.
a. Rationale: Prevention of contractures and support of
self-calming techniques of neonates (prone, sidelying) (Figs. 4.7 and 4.8) (4).
8. Pad bony prominences and maintain natural curvature
of extremities (especially the hand and fingers)
32 Section I ■ Preparation and Support
a. Rationale: Prevents contractures and neurovascular
injury; preserves skin integrity; reduces friction and
pressure to skin from restraint material (1)
9. When utilizing tape for securing an extremity to a
board, use transparent tape when possible to allow for
careful and complete assessment of the underlying
skin. Do not apply tape too securely, as it may impede
circulation. Tips of all digits should remain visible for
10. Restraints on the upper or lower extremities need to be
assessed at least hourly (and/or according to hospital
policy and regulatory agency requirement (the Joint
a. Skin Integrity, including excoriation, erythema, and
11. Check for possible constriction by inserting a finger
between infant’s skin and the secured restraint (2).
a. Rationale: Constriction from a tight restraint can
cause neurovascular injury and impede circulation.
No comments:
Post a Comment
اكتب تعليق حول الموضوع